10:44 AM EST, 01/15/2025 (MT Newswires) -- Becton, Dickinson and Co. ( BDX ) said Wednesday it plans to increase capacity for critical medical devices by making new investments in its manufacturing facilities in the US.

The company intends to invest more than $30 million this year to increase manufacturing capacity for IV lines at its Utah plant.

Becton, Dickinson ( BDX ) said it installed new needle and syringe production lines at its plants in Connecticut and Nebraska as part of its 2024 investment of more than $10 million. One line is now fully operational, while additional lines are likely to start up in the coming months, the company said.

Price: 235.45, Change: -0.35, Percent Change: -0.15